NCT01730768View on ClinicalTrials.gov

A Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

147

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Schizophrenia
Interventions
DRUG

AQW051

DRUG

Placebo

Trial Locations (13)

10305

Novartis Investigative Site, Staten Island

10312

Novartis Investigative Site, Staten Island

19131

Novartis Investigative Site, Philadelphia

30308

Novartis Investigative Site, Atlanta

33025

Novartis Investigative Site, Miramar

75062

Novartis Investigative Site, Irving

90660

Novartis Investigative Site, Pico Rivera

91206

Novartis Investigative Site, Glendale

91950

Novartis Investigative Site, National City

92102

Novartis Investigative Site, San Diego

92845

Novartis Investigative Site, Garden Grove

94612

Novartis Investigative Site, Oakland

08053

Novartis Investigative Site, Marlton

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY